ESTIMATION OF METASTATIC NEOGENESIS IN ASCITIC EXUDATE BY AN AUTOMATED ANALYSIS OF BIOLOGICAL LIQUIDS
https://doi.org/10.25207/1608-6228-2019-26-1-58-66
Abstract
The aim is to carry out an automated analysis of biological liquids for the estimation of metastatic neogenesis in ascitic exudates.
Materials and methods. A retrospective analysis of 40 case histories of patients with the ascitic syndrome of non-tumour (cirrhotic) and tumour genesis was performed. Traditional cytology was accompanied by an automated analysis of exudative fluids. The final diagnosis was verified using instrumental and pathomorphological methods. The processing of statistical data included an assessment of the intergroup difference significance.
Results. Compared with cirrhotic ascites, the following parameters of the automated analysis of biological fluids are found to be statistically significant (p30% in the atypical cell screening system has been established. In the absence of an acute inflammatory reaction, the presence of eosinophils in the exudate should be interpreted as an indirect marker of a tumour process. According to the data obtained, the content of neutrophils, lymphocytes and monocytes in ascitic fluids does not depend on the nature of the process (p>0.05).
Conclusion. The diagnostic capabilities of automated analysis of ascitic fluids are analysed. In the system of differential diagnosis of tumour and non-tumour processes, the following parameters are established to possess the greatest informative value: TCN, HF, and the presence of eosinophils (EO).
Conflict of interest: the authors declare no conflict of interest.
About the Authors
Irina B. Baranovskaya
Regional Clinical Hospital No. 2
Russian Federation
tel.: +7 (961) 533-06-80; Chekistov ave., 4/117, Krasnodar, 350089
Russian Federation
tel.: +7 (961) 533-06-80; Chekistov ave., 4/117, Krasnodar, 350089
Ol’ga F. Samokhina
Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Galina A. Demidchenko
Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Irina P. Sysoeva
Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
References
1. Dolgov V.V., Shabalova I.P., Mironova I.I., Dzhangirova T.V., Korotaev A.L. Ejection fluids. Laboratory analysis. M.: Triada; 2006: 243 (In Russ.).
2. Danise P., Maconi M., Rovetti A. et al. Cell counting of body fluids: comparison between three automated haematology analysers and the manual microscope method. Int. J. Lab. Hematol. 2013; 35(6): 608–613. DOI: 10.1111/ijlh.12093
3. Kiskun A.A. Obstacles on the way of centralizing clinical and laboratory investigations. Menedzher Zdravookhraneniya. 2014. 11: 11–26 (In Russ., English abstract).
4. Ai T., Tabe Y., Takemura H. et al. Novel flowcytometry-based approach of malignant cell detection in body fluids using an automated hematology analyzer. PLoS One. 2018; 13(2): e0190886. DOI: 10.1371/ journal.pone.0190886
5. Burri E., Schulte F., Muser J. et al. Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count. World. J. Gastroenterol. 2013; 19(13): 2028–2036. DOI: 10.3748/wjg.v19.i13.2028
6. Cho Y.U., Chi H.S., Park S.H. et al. Body fluid cellular analysis using the Sysmex XN-2000 automatic hem atology analyzer: focusing on malignant samples. Int. J. Lab. Hematol. 2015; 37(3): 346–356. DOI: 10.1111/ ijlh.12292
7. Fleming C., Brouwer R., Lindemans J., de Jonge R. Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids. Clin. Chem. Lab. Med. 2012; 50(10): 1791–1798. DOI: 10.1515/cclm-2011-0927
8. Labaere D., Boeckx N., Geerts I. et al. Detection of malignant cells in serous body fluids by counting high-fluorescent cells on the Sysmex XN-2000 hematology analyzer. Int. J. Lab. Hematol. 2015; 37(5): 715–722. DOI: 10.1111/ijlh.12393
9. Szamosi D., Bautista J., Cornbleet J. et al. Body fluid analysis for cellular composition; Approved guideline. CLSI document H56-A. 2006: 26.
10. Rimola A., García-Tsao G., Navasa M. et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J. Hepatol. 2000; 32(1): 142–153.
11. Xu W., Yu Q., Xie L. et al. Evaluation of Sysmex XN1000 hematology analyzer for cell count and screening of malignant cells of serous cavity effusion. Medicine (Baltimore). 2017; 96(27): e7433. DOI: 10.1097/ MD.0000000000007433
Review
For citations:
Baranovskaya I.B., Samokhina O.F., Demidchenko G.A., Sysoeva I.P. ESTIMATION OF METASTATIC NEOGENESIS IN ASCITIC EXUDATE BY AN AUTOMATED ANALYSIS OF BIOLOGICAL LIQUIDS. Kuban Scientific Medical Bulletin. 2019;26(1):58-66. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-1-58-66
Views:
480
Email this article 